Therapy Equipment has been acquired by ESAB Corporation
Owner Venture Managers has sold Therapy Equipment Ltd. to ESAB Corporation.
Founded in 1983, Therapy Equipment is a regional leader in the medical gas control market for suction and oxygen equipment. The business holds strong market leadership across the UK and the portfolio includes trusted suction equipment, flowmeters and medical regulators used in healthcare facilities across the region and internationally.
Headquartered in the US, ESAB Corporation is a leading global gas control company with supplier-of-choice brands across the world for the industrial, medical and specialty gas industries.
Owner Venture Managers is a venture capital and private equity company based in the UK. It partners and invests alongside a network of sector-focused operating partners, who are highest-caliber individuals with proven track records of profit improvement performance and acquisition-led growth in the relevant industry of the target entity.
Oaklins Cavendish, based in the UK, advised on the sale of Therapy Equipment to ESAB Corporation.
James Wooster
Director, Owner Venture Managers
Talk to the deal team
Related deals
Bluegem Capital Partners and AREV Partners have acquired 100% of Groupe Pinard
Bluegem Capital Partners and AREV Partners have successfully completed the acquisition of the prestigious Groupe Pinard from IK Partners.
Learn moreLumiforte partners with Kartesia to propel global growth and innovation
Lumiforte, a global leader in innovative smart coatings for greenhouse horticulture, sports line-marking and other functional coatings for agriculture and industry, is excited to announce an investment from Kartesia, a European specialist in capital solutions for small and medium-sized companies. Horticoop, a longstanding shareholder of Lumiforte and a key player in the horticultural industry through its investment cooperative, continues to remain a shareholder.
Learn morePanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production
PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.
Learn more